{"id":107516,"date":"2026-06-17T07:06:26","date_gmt":"2026-06-17T11:06:26","guid":{"rendered":"https:\/\/www.curejm.org\/?p=107516"},"modified":"2026-06-17T07:09:05","modified_gmt":"2026-06-17T11:09:05","slug":"junio-de-2026-ayuntamiento-auto-t","status":"publish","type":"post","link":"https:\/\/www.curejm.org\/es\/june-2026-town-hall-car-t\/","title":{"rendered":"Reuni\u00f3n p\u00fablica de junio de 2026 \u2013 CAR-T"},"content":{"rendered":"<p class=\"wp-block-paragraph\">El 16 de junio, Shannon Malloy, de Cure JM, se reuni\u00f3 con <strong>Tania Gonz\u00e1lez Rivera<\/strong>, vicepresidente de Asuntos M\u00e9dicos, y <strong>Courtney Little<\/strong>, directora s\u00e9nior y cient\u00edfica cl\u00ednica de Cabaletta Bio, para una conversaci\u00f3n sobre el ensayo RESET-Myositis CAR-T y las \u00faltimas novedades en investigaci\u00f3n presentadas en el congreso europeo de reumatolog\u00eda. <strong>Dra. Holly Wobma<\/strong>, reumat\u00f3logo pedi\u00e1trico del Boston Children\u2019s Hospital y de la Facultad de Medicina de Harvard, tambi\u00e9n se uni\u00f3 al debate para ayudar a las familias a comprender c\u00f3mo funciona la terapia CAR-T y qu\u00e9 implica esto, desde el punto de vista cient\u00edfico, espec\u00edficamente para los pacientes con miositis juvenil.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">En la conversaci\u00f3n se trataron los siguientes temas:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u2022 c\u00f3mo funciona la terapia CAR-T <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u2022 c\u00f3mo son el tratamiento y la inscripci\u00f3n <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u2022 resultados cl\u00ednicos preliminares y observaciones sobre la seguridad <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u2022 lo que los investigadores han descubierto hasta ahora <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u2022 c\u00f3mo las familias pueden averiguar si su ni\u00f1o, adolescente o adulto joven podr\u00eda cumplir con los requisitos en un centro cercano<\/p>\n\n\n\n<figure class=\"wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">\n<iframe title=\"Reuni\u00f3n p\u00fablica de Cure JM, 16 de junio. Biograf\u00eda de Cabaletta\" width=\"800\" height=\"450\" src=\"https:\/\/www.youtube.com\/embed\/1VO1xCIgEh0?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe>\n<\/div><\/figure>","protected":false},"excerpt":{"rendered":"<p>On June 16, Cure JM\u2019s Shannon Malloy sat down with Tania Gonzalez Rivera, VP of Medical Affairs, and Courtney Little, Senior Director and Clinical Scientist at Cabaletta Bio, for a conversation about the RESET\u2011Myositis CAR\u2011T trial and new research updates presented at the European rheumatology conference. Dr. Holly Wobma, pediatric rheumatologist at Boston Children\u2019s Hospital [&hellip;]<\/p>\n","protected":false},"author":24,"featured_media":107523,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","_seopress_robots_follow":"","_seopress_robots_imageindex":"","_seopress_robots_snippet":"","_seopress_robots_primary_cat":"","_seopress_robots_breadcrumbs":"","_seopress_robots_freeze_modified_date":"","_seopress_robots_custom_modified_date":"","_seopress_robots_canonical":"","_seopress_social_fb_title":"","_seopress_social_fb_desc":"","_seopress_social_fb_img":"","_seopress_social_fb_img_attachment_id":0,"_seopress_social_fb_img_width":0,"_seopress_social_fb_img_height":0,"_seopress_social_twitter_title":"","_seopress_social_twitter_desc":"","_seopress_social_twitter_img":"","_seopress_social_twitter_img_attachment_id":0,"_seopress_social_twitter_img_width":0,"_seopress_social_twitter_img_height":0,"_seopress_redirections_value":"","_seopress_redirections_enabled":"","_seopress_redirections_enabled_regex":"","_seopress_redirections_logged_status":"","_seopress_redirections_param":"","_seopress_redirections_type":0,"_seopress_analysis_target_kw":"","_seopress_news_disabled":"","_seopress_video_disabled":"","_seopress_video":[],"_seopress_pro_schemas_manual":[],"_seopress_pro_rich_snippets_disable_all":"","_seopress_pro_rich_snippets_disable":[],"_seopress_pro_schemas":[],"footnotes":""},"categories":[77,82],"post_tag":[71],"class_list":["post-107516","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-clinicians","category-families","tag-page-town-halls"],"_links":{"self":[{"href":"https:\/\/www.curejm.org\/es\/wp-json\/wp\/v2\/posts\/107516","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.curejm.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.curejm.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.curejm.org\/es\/wp-json\/wp\/v2\/users\/24"}],"replies":[{"embeddable":true,"href":"https:\/\/www.curejm.org\/es\/wp-json\/wp\/v2\/comments?post=107516"}],"version-history":[{"count":0,"href":"https:\/\/www.curejm.org\/es\/wp-json\/wp\/v2\/posts\/107516\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.curejm.org\/es\/wp-json\/wp\/v2\/media\/107523"}],"wp:attachment":[{"href":"https:\/\/www.curejm.org\/es\/wp-json\/wp\/v2\/media?parent=107516"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.curejm.org\/es\/wp-json\/wp\/v2\/categories?post=107516"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.curejm.org\/es\/wp-json\/wp\/v2\/post_tag?post=107516"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}